Surgical endoscopy · 2026
EUS-FNA improves diagnosis of extraluminal anastomotic recurrence after surgery.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yu Huiyuan, Li Mingtang, Che Yanjie, Zhao Jing, Li Sha, Xu Longjiang, Cheng Guilian, Xu Liming, Wu Wei, Bao Run, Zhang Yirui, Qian Mingjie, Hu Duanmin
Аннотация
BACKGROUND: Early diagnosis of extraluminal locoregional recurrence (LRR) near the anastomosis after surgery for gastrointestinal malignancies is challenging. This study evaluated the diagnostic performance of endoscopic ultrasound (EUS), EUS-guided fine-needle aspiration (EUS-FNA), and an integrated diagnostic pathway in this context.
METHODS: We retrospectively analyzed patients who underwent EUS at our hospital between April 2014 and April 2025 for suspected extraluminal LRR. We collected clinical, procedural, and pathological data. Each patient had at least 6 months of clinical-imaging follow-up. The final diagnosis was based on pathology (surgical or EUS-FNA) or confirmed disease progression and served as the reference standard for calculating diagnostic performance.
RESULTS: Seventy-seven patients were included. EUS identified suspicious extraluminal lesions in 37 patients; 35 of these underwent EUS-FNA. EUS alone demonstrated a sensitivity of 94.6% (95% CI 81.8-99.3%), specificity of 95.0% (95% CI 83.1-99.4%), and accuracy of 94.8%. The corresponding values for EUS-FNA were 93.9% (95% CI 79.8-99.3%), 100.0% (95% CI 15.8-100.0%), and 94.3%, respectively, while the integrated diagnostic strategy achieved 89.2% (95% CI 74.6-97.0%), 100.0% (95% CI 91.2-100.0%), and 94.8%, respectively. The subgroup analysis showed the high sensitivity of EUS-FNA in all recurrence patterns, tumor types, and anastomotic sites (≥ 83.3%). According to the surgical pathological findings of the primary tumor, the recurrence rate was significantly higher in patients with elevated-risk (57.1% vs 23.8%; OR 4.27, 95% CI 1.38-13.2; P = 0.011), but EUS-FNA still achieved a sensitivity of 92.9%.
CONCLUSIONS: Combining EUS with selective EUS-FNA provides an accurate and safe strategy for detecting extraluminal LRR. This approach uses EUS's high sensitivity for lesions and definitive pathology from EUS-FNA, significantly enhancing the accuracy of postoperative surveillance for extraluminal anastomotic LRR.
METHODS: We retrospectively analyzed patients who underwent EUS at our hospital between April 2014 and April 2025 for suspected extraluminal LRR. We collected clinical, procedural, and pathological data. Each patient had at least 6 months of clinical-imaging follow-up. The final diagnosis was based on pathology (surgical or EUS-FNA) or confirmed disease progression and served as the reference standard for calculating diagnostic performance.
RESULTS: Seventy-seven patients were included. EUS identified suspicious extraluminal lesions in 37 patients; 35 of these underwent EUS-FNA. EUS alone demonstrated a sensitivity of 94.6% (95% CI 81.8-99.3%), specificity of 95.0% (95% CI 83.1-99.4%), and accuracy of 94.8%. The corresponding values for EUS-FNA were 93.9% (95% CI 79.8-99.3%), 100.0% (95% CI 15.8-100.0%), and 94.3%, respectively, while the integrated diagnostic strategy achieved 89.2% (95% CI 74.6-97.0%), 100.0% (95% CI 91.2-100.0%), and 94.8%, respectively. The subgroup analysis showed the high sensitivity of EUS-FNA in all recurrence patterns, tumor types, and anastomotic sites (≥ 83.3%). According to the surgical pathological findings of the primary tumor, the recurrence rate was significantly higher in patients with elevated-risk (57.1% vs 23.8%; OR 4.27, 95% CI 1.38-13.2; P = 0.011), but EUS-FNA still achieved a sensitivity of 92.9%.
CONCLUSIONS: Combining EUS with selective EUS-FNA provides an accurate and safe strategy for detecting extraluminal LRR. This approach uses EUS's high sensitivity for lesions and definitive pathology from EUS-FNA, significantly enhancing the accuracy of postoperative surveillance for extraluminal anastomotic LRR.